<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01358201</url>
  </required_header>
  <id_info>
    <org_study_id>PETHEMA LAL-07FRAIL</org_study_id>
    <nct_id>NCT01358201</nct_id>
  </id_info>
  <brief_title>PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years</brief_title>
  <official_title>Treatment Protocol For All Fragile Patients Ph' Negative Over 55 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PETHEMA Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>PETHEMA Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The biological characteristics of the adult LAL, karyotypic and phenotypic particular, are
      fundamentally different from those of Acute Lymphoblastic Leukemia (ALL) children and,
      consequently, the results of treatment are substantially lower. Additionally, elderly
      patients tolerate the drugs considered relatively low-key in the management of the LAL and
      suffer more toxicity. Although the LAL is much more common in patients over 60 years of age
      than in younger adults, older adults with ALL are clearly underrepresented in prospective
      controlled studies. A good portion of elderly patients are not able to tolerate the intensity
      of the standard treatment applied to children or young adults and a significant portion of
      them receive only palliative or supportive treatment. The data in the literature relating
      specifically to the elderly population are scarce and most of them have obtained a
      stratification by age of study designed for young people (CALGB, GMALL, PETHEMA). To date,
      the group's recommendation was to treat PETHEMA the LAL-96RI protocol for elderly patients
      because this protocol less aggressive than those used in high-risk ALL. However, the
      development of inhibitors of tyrosine kinases LAL effective in Bcr / abl positive, a
      relatively common type of LAL in the older patient, requires a differentiated treat these
      patients. Moreover, analysis of data from patients treated so far with the LAL-96RI protocol
      has shown mediocre results even for LAL Bcr / abl negative. This analysis also showed a
      significant benefit in survival related to the reduction of treatment (removal of the
      L-asparaginase during induction and cyclophosphamide at the end of induction) attributed to a
      reduction in toxicity
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prephase (days -5 to -1) Dexamethasone 10 mg/m2 bolus day EV for 5 days (-5 to -1).
      Supplementary treatment: hydration minimum 2000 ml / day. allopurinol 300 mg / day. gastric
      protection (as center). daily monitoring of blood glucose daily monitoring of renal function.

      Intrathecal treatment (diagnosis and prophylactic / therapeutic) day -5: 12 mg were
      administered intrathecal methotrexate. The morphological study of the CSF will be defining
      initial CNS involvement by LAL. Although it is recommended immunophenotypic study of CSF, the
      definition of CNS involvement by LAL (and its therapeutic consequences) based on
      morphological observation of blasts in CSF cytocentrifuge.

      Remission induction :

      Tolerance prephase period can be used to establish the final indication of treatment
      (standard protocol or frail patients). Day 0 is free of treatment and is considered as +1 the
      first day of induction.

      Systemic treatment

        -  Vincristine (VCR) 1 mg (absolute dose) EV 1, 8, 15 and 22.

        -  Dexamethasone (DEX): 10 mg/m2 EV, IM or PO days 1-2, 8-9 days 15-16, 22-23.

      Intrathecal chemotherapy

      Triple therapy was administered with methotrexate (MTX), cytosine arabinoside (ARA-C) and
      hydrocortisone, days 1, 8, 15 and 22 (five doses total prophylactic between prephase and
      induction):

      MTX 12 mg ARA-C 40 mg Dexamethasone 4 mg

      If initial infiltration of the CNS is administered once every 72 hours until the
      disappearance of blast cell morphology CSF (cytocentrifugation) in at least two consecutive
      taps. Alternatively be administered liposomal cytarabine (DepoCyt) fortnightly if authorized
      by the center or in the context of a clinical trial

      Maintenance treatment of first year :

      Maintenance during the first year will start after full recovery after induction and after
      complete reassessment of the disease (including myelogram) and will last until one year from
      the time of documentation of complete remission.

      The basic treatment to include mercaptopurine 50 mg/m2 PO day and methotrexate 20 mg/m2 IM
      weekly.

      Once every 3 months will be added to maintenance treatment a &quot;mini-reinduction&quot; consisting

        -  VCR: 1 mg (absolute dose), i.v., day 1.

        -  Dexamethasone 40 mg / day, i.v. or p.o., days 1-2.

        -  Not considered more doses of triple intrathecal therapy. Reinduction only be practiced
           during the first year after remission, so a total of 4 quarterly.

      Maintenance of the second year:

      After the first year of maintenance will perform a complete reassessment of the disease
      (including myelogram) and if the patient remains in complete remission maintenance will
      continue (without reinduction) until two years from the time of diagnosis.

      The initial dose of mercaptopurine and methotrexate will be identical to the first year. Must
      comply (by increases or decreases of 20% of the dose) to maintain the numbers of neutrophil
      counts between 1.5 and 3x109/l and platelets above 100x109 / L
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy in terms of response rate</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy in terms disease free survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy in terms of global survival</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Lymphoblastic Leukemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vINCRISTINE</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methotrexate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cytosine arabinoside</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adults over 55 years diagnosed with acute lymphoblastic leukemia Ph 'negative and not
        previously treated with frailty (&gt; 3 points in the Charlson comorbidity index)

        Exclusion Criteria:

        LAL

        1. L3 type mature B phenotype (sIg +) or cytogenetic abnormalities characteristic of
        Burkitt LAL (t [8, 14], t [2, 8], t [8, 22]).

        2 . biphenotypic acute leukemias and bilinear 3 . acute undifferentiated leukemia 4 .
        Patients with a Charlson comorbidity index less than or equal to 3 (and therefore that
        could potentially benefit from more intensive treatment PETHEMA LAL-07OLD).

        5 . General condition affected (grades 3 and 4 WHO scale), not attributable to the LAL.

        6 . LAL Ph 'positive (though still must register their LAL07OPH specific protocol).

        7 . Lack of consent by the patient to use their clinical data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Josep MÂª Ribera, Dr</last_name>
    <email>jmribera@iconcologia.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>H. Son Llatzer</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bargay Lleoneart Joan, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Consorci Sanitari de Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica Universitaria de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prosper Felipe, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Prosper Felipe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Santiago JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FundaciÃ³n Hospital AlcorcÃ³n</name>
      <address>
        <city>AlcorcÃ³n</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>PeÃ±alver Francisco Javier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de AlcorcÃ³n</name>
      <address>
        <city>AlcorcÃ³n</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PeÃ±alver Francisco, Dr</last_name>
    </contact>
    <investigator>
      <last_name>PeÃ±alver Francisco, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoapital General</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernandez Abellan Pascual, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rivas ConcepciÃ³n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FernÃ¡ndez AbellÃ¡n Pascual, Dr</last_name>
    </contact>
    <investigator>
      <last_name>FernÃ¡ndez AbellÃ¡n Pascual, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ribera Josep MÂª, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ribera Josep MÂª, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic y Provincial de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esteve Jordi, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Esteve Jordi, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau.</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sierra Jordi, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Abella Eugenia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Valle HebrÃ³n</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bueno Javier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut CatalÃ  d'oncologÃ­a</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BoquÃ© Concha, Dr</last_name>
    </contact>
    <investigator>
      <last_name>BoquÃ© Concha, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Basurtuko Ospitalea</name>
      <address>
        <city>Basurto</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beltran de Heredia JosÃ© MÂª, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Beltran de Heredia Jose MÂª, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Amutio DÃ­ez Elena, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de CÃ¡ceres</name>
      <address>
        <city>CÃ¡ceres</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bergua Juan Miguel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Bergua Juan Miguel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Reina SofÃ­a</name>
      <address>
        <city>CÃ³rdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torres Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Torres Antonio, DR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Area Hospitalaria Juan RamÃ³n Jimenez</name>
      <address>
        <city>Huelva</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FernÃ¡ndez Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>FernÃ¡ndez Antonio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital MÃ©dico QuirÃºrgico Ciudad de JaÃ©n</name>
      <address>
        <city>Jaen</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alcala Antonio, Dr</last_name>
    </contact>
    <investigator>
      <last_name>AlcalÃ¡ Antonio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. de Jerez</name>
      <address>
        <city>Jerez de la Frontera</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JosÃ© Luis GuzmÃ¡n Zamudio , Dr</last_name>
    </contact>
    <investigator>
      <last_name>GuzmÃ¡n Zamudio JosÃ© Luis, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Juan Canalejo</name>
      <address>
        <city>La CoruÃ±a</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deben Guillermo, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Deben Guillermo, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario LeÃ³n</name>
      <address>
        <city>Leon</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fuertes NuÃ±ez Marta, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanchez Juan Manuel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Sanchez Juan Manuel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Xeral-Calde</name>
      <address>
        <city>Lugo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Arias JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica La ConcepciÃ³n</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RomÃ¡n Alejandro, Dr</last_name>
    </contact>
    <investigator>
      <last_name>RomÃ¡n Alejandro, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Krisnk Isabel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica RÃºber</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>MartÃ­nez Carmen, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FundaciÃ³n JimÃ©nez DÃ­az</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Prieto Elena, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre. Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lahuerta juan JosÃ©, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Lahuerta Juan JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MartÃ­nez Rafael, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Martinez Rafael, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico San Carlos de Madrid</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diaz Mediavilla Joaquin, Dr</last_name>
    </contact>
    <investigator>
      <last_name>DÃ­az Mediavilla JoaquÃ­n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Fuenlabrada</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HernÃ¡ndez Rivas JosÃ© Angel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>HernÃ¡ndez Rivas JosÃ© Angel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Princesa</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AdriÃ¡n Alegre, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Alegre AdriÃ¡n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Madrid, S.A.- Norte Hospital General</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>PÃ©rez de Oteyza Jaime, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Canales Miguel Ãngel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Canales Miguel Angel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Althaia, Xarxa Asistencial de Manresa</name>
      <address>
        <city>Manresa</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Subira Maricel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FundaciÃ³n Hospital Sant Joan de DÃ©u de Martorell</name>
      <address>
        <city>Martorell</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Las Heras German, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Morales Meseguer</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>De Arriba Felipe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Morales Messeguer. Murcia</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amigo MÂª Luz, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Amigo MÂª Luz, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sta. Maria del Rosell</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>IbaÃ±ez JerÃ³nima, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>. Hospital ClÃ­nico Universitario Virgen de la Victoria</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Moreno MÂª JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospital Costa del Sol</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MarÃ­a Casanova Espinosa , Dr</last_name>
    </contact>
    <investigator>
      <last_name>Casanova Espinosa MarÃ­a, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>H. Carlos Haya</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Negri Silvia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Carlos Haya</name>
      <address>
        <city>MÃ¡laga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barrios Manuel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Barrios Manuel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RayÃ³n MC, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del RÃ­o CarriÃ³n</name>
      <address>
        <city>Palencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ortega Frenando, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ortega Fernando, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Son Dureta</name>
      <address>
        <city>Palma de Mallorca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sampol Antonia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Pontevedra_Hospital Montecelo</name>
      <address>
        <city>Pontevedra</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Allegue MÂª JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Pontevedra_Hospital Provincial</name>
      <address>
        <city>Pontevedra</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Constela Manuel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CorporaciÃ³ Sanitaria Parc TaulÃ­</name>
      <address>
        <city>Sabadell</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>RÃ¡mila Elena, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Del CaÃ±izo Consuelo, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>San Miguel JesÃºs, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Mateos Maria Victoria, Dr</last_name>
    </contact_backup>
    <investigator>
      <last_name>San Miguel Izquierdo JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HernÃ¡ndez Rivas JosÃ© MÂª, Dr</last_name>
    </contact>
    <investigator>
      <last_name>HernÃ¡ndez Rivas JosÃ© MÂª, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mateos MÂª Victoria, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Mateos MÂª Victoria, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mateo Gema, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>GarcÃ­a Sanz RamÃ³n, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica Sant Camil</name>
      <address>
        <city>Sant Pere de Ribes</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Asensio Antonio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoaspital MarquÃ©s de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Conde Eulogio, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Santiago</name>
      <address>
        <city>Santiago de Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bello Jose Luis, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Segovia</name>
      <address>
        <city>Segovia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>HernÃ¡ndez JosÃ© Mariano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Regional Virgen del RocÃ­o</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MartÃ­n SÃ¡nchez JesÃºs, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Martin Sanchez JesÃºs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Escoda Lourdes, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Escoda Lourdes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General</name>
      <address>
        <city>V alencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carbonell FÃ©lix, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Carbonell FÃ©lix, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FundaciÃ³n Instituto Valenciano de OncologÃ­a</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Llorente Pablo, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hoapital La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanz Miguel Angel, Dr</last_name>
      <phone>96 386 27 58</phone>
      <email>msanz@uv.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Valencia.</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tormo Mar, Dra</last_name>
    </contact>
    <investigator>
      <last_name>Teruel CasasÃºs Ana Isabel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tormo Mar, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nic</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terol Maria JosÃ©, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Terol MÂª JosÃ©, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Dr Pesset</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferrer Secundino, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Ferrer Secundino, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>De la Rubia Javier, Dr</last_name>
      <email>delarubia_jav@gva.es</email>
    </contact>
    <investigator>
      <last_name>De la Rubia Javier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital ClÃ­nico de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fernandez Calvo Francisco, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Vigo</name>
      <address>
        <city>Vigo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>PoderÃ³s ConcepciÃ³n, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comarcal de Vinaros</name>
      <address>
        <city>Vinaros</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Montagud Mario, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Palomera Bernal Luis, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Lozano Blesa. Zaragoza</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olave MÂª Teresa, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Olave MÂª Teresa, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2011</study_first_submitted>
  <study_first_submitted_qc>May 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2011</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Lymphoblastic Leukemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Vincristine</mesh_term>
    <mesh_term>Cytarabine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

